A mouse model of familial hypertrophic cardiomyopathy

被引:420
|
作者
GeisterferLowrance, AAT
Christe, M
Conner, DA
Ingwall, JS
Schoen, FJ
Seidman, CE
Seidman, JG
机构
[1] HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115
[3] BRIGHAM & WOMENS HOSP,DEPT MED,BOSTON,MA 02115
[4] BRIGHAM & WOMENS HOSP,DEPT PATHOL,BOSTON,MA 02115
[5] BRIGHAM & WOMENS HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115
关键词
D O I
10.1126/science.272.5262.731
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A mouse model of familial hypertrophic cardiomyopathy (FHC) was generated by the introduction of an Arg(403)-->Gln mutation into the alpha cardiac myosin heavy chain (Mwc) gene. Homozygous alpha MHC(403/403) mice died 7 days after birth, and sedentary heterozygous alpha MHC(403/+) mice survived for 1 year. Cardiac histopathology and dysfunction in the alpha MHC(403/+) mice resembled human FHC. Cardiac dysfunction preceded histopathologic changes, and myocyte disarray, hypertrophy, and fibrosis increased with age. Young male alpha MHC(403/+) mice showed more evidence of disease than did their female counterparts. Preliminary results suggested that exercise capacity may have been compromised in the alpha MHC(403/+) mice. This mouse model may help to define the natural history of FHC.
引用
收藏
页码:731 / 734
页数:4
相关论文
共 50 条
  • [2] A transgenic mouse model of familial hypertrophic cardiomyopathy
    Ohta, M
    Takaoka, Y
    Suzuki, M
    Takahashi, F
    Minakami, R
    Sasaguri, T
    Ohtsuki, I
    Yamamura, K
    Morimoto, S
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 63P - 63P
  • [3] TRANSGENIC MOUSE MODEL FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY
    VIKSTROM, KL
    FACTOR, SM
    LEINWAND, LA
    [J]. CIRCULATION, 1994, 90 (04) : 521 - 521
  • [4] A mouse model of familial hypertrophic cardiomyopathy caused by a α-tropomyosin mutation
    Rethinasamy Prabhakar
    Natalia Petrashevskaya
    Arnold Schwartz
    Bruce Aronow
    Greg P. Boivin
    Jeffery D. Molkentin
    David F. Wieczorek
    [J]. Molecular and Cellular Biochemistry, 2003, 251 : 33 - 42
  • [5] A mouse model for α-tropomyosin mutation that causes familial hypertrophic cardiomyopathy
    Prabhakar, R
    Boivin, GP
    Grupp, I
    Artega, G
    Aronow, B
    Solaro, RJ
    Wieczorek, DF
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (06) : A96 - A96
  • [6] A mouse model of familial hypertrophic cardiomyopathy caused by a α-tropomyosin mutation
    Prabhakar, R
    Petrashevskaya, N
    Schwartz, A
    Aronow, B
    Boivin, GP
    Molkentin, JD
    Wieczorek, DF
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 251 (1-2) : 33 - 42
  • [7] A mouse model of myosin binding protein C familial hypertrophic cardiomyopathy
    Yang, QL
    Sanbe, A
    Osinska, HE
    Hewett, TE
    Klevitsky, R
    Robbins, J
    [J]. CIRCULATION, 1998, 98 (17) : 626 - 626
  • [8] Cardiac function of a transgenic mouse model of familial hypertrophic cardiomyopathy.
    Ohta, M
    Du, CK
    Oka, N
    Miyazaki, H
    Takaoka, Y
    Suzuki, M
    Lu, QW
    Minakami, R
    Imaizumi, T
    Sasaguri, T
    Ohtsuki, I
    Yamamura, K
    Morimoto, S
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 104P - 104P
  • [9] Familial hypertrophic cardiomyopathy: man, mouse and cat
    Baty, C
    Watkins, H
    [J]. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1998, 91 (12): : 791 - 793
  • [10] A frog model of familial hypertrophic cardiomyopathy
    Brittingham, JW
    Weeks, DL
    [J]. DEVELOPMENTAL BIOLOGY, 1999, 210 (01) : 238 - 238